1.	Comparison of Endoscopic Radiofrequency Ablation Versus Photodynamic Therapy for Inoperable Cholangiocarcinoma Phase: Phase III, Phase II Type: Treatment Status: Active Age: 18 to 70 Sponsor: Other Protocol IDs: RFA2012, NCT01739465
2.	Photodynamic Therapy (PDT) for Palliation of Cholangiocarcinoma Phase: Phase III, Phase II Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 1110011999, NCT01755013
3.	S-1 and Photodynamic Therapy in Cholangiocarcinoma Phase: Phase III Type: Treatment Status: Active Age: 18 to 90 Sponsor: Other Protocol IDs: 2009-0056, NCT00869635
4.	Photodynamic Therapy in Treating Patients With Resectable Non-Small Cell Lung Cancer That Has Spread to the Pleura Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000583050, UPCC-05503, 709070, UPCC-709070, NCT00601848
5.	Efficacy and Safety of a Sunscreen Against Porfimer Sodium-induced Phototoxicity to Visible Light Phase: Phase II Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Approved-not yet active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: MA-PO-PHOTB05-01, NCT01256203
6.	Photodynamic Therapy (PDT) for Brain Tumors Phase: Phase I Type: Treatment Status: Active Age: 18 and under Sponsor: Other Protocol IDs: 163588-1, NCT01682746
7.	Ultrasound-Guided Photodynamic Therapy With Photofrin & Gemcitabine for Patients With Locally Advanced Pancreatic Cancer Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 to 60 Sponsor: Other Protocol IDs: IUCRO-0319, 1207009096, NCT01770132
8.	Photodynamic Therapy Using Porfimer Sodium in Treating Patients With Non-Small Cell Lung Cancer And Bronchial Disease Phase: No phase specified Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: Not specified Sponsor: NCI, Other Protocol IDs: CDR0000614438, OSU-07115, OSU-2008C0055, NCT00754910